In CRC, the capability of cancer cells isolated from primary tumors to form xenografts when injected in immunodeficient mice was reserved to a small subset of cells showing EpCAMhigh/CD44+ expression [6]. This evidence concerns the gene CD44 and colorectal carcinoma.